No connection

Search Results

IVVD vs MCTA

IVVD
Invivyd, Inc.
BEARISH
Price
$1.76
Market Cap
$497.7M
Sector
Healthcare
AI Confidence
90%
MCTA
Charming Medical Limited
BEARISH
Price
$29.36
Market Cap
$504.3M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
IVVD
--
MCTA
419.36
Forward P/E
IVVD
-8.0
MCTA
--
P/B Ratio
IVVD
2.05
MCTA
9785.0
P/S Ratio
IVVD
9.31
MCTA
92.98
EV/EBITDA
IVVD
-4.98
MCTA
388.4

Profitability

Gross Margin
IVVD
92.99%
MCTA
96.02%
Operating Margin
IVVD
-72.96%
MCTA
-0.94%
Profit Margin
IVVD
-98.25%
MCTA
12.12%
ROE
IVVD
-33.97%
MCTA
--
ROA
IVVD
-17.09%
MCTA
10.63%

Growth

Revenue Growth
IVVD
24.5%
MCTA
-27.0%
Earnings Growth
IVVD
--
MCTA
--

Financial Health

Debt/Equity
IVVD
0.01
MCTA
1.6
Current Ratio
IVVD
7.24
MCTA
0.59
Quick Ratio
IVVD
7.06
MCTA
0.57

Dividends

Dividend Yield
IVVD
--
MCTA
--
Payout Ratio
IVVD
0.0%
MCTA
0.0%

AI Verdict

IVVD BEARISH

Invivyd exhibits critical financial weakness, highlighted by a Piotroski F-Score of 0/9, indicating a complete lack of fundamental improvement across all measured categories. While the company maintains a strong liquidity position with a Current Ratio of 7.24 and very low debt, it is suffering from extreme operational inefficiency with a profit margin of -98.25%. There is a stark disconnect between the analyst 'Strong Buy' consensus (Target $10.00) and the deterministic data, which shows consistent earnings misses and bearish insider activity.

Strengths
High Gross Margin (92.99%) suggesting strong product pricing potential
Strong short-term liquidity with a Current Ratio of 7.24
Very low leverage with a Debt/Equity ratio of 0.01
Risks
Severe operational losses with a profit margin of -98.25%
Deterministic health failure (Piotroski F-Score 0/9)
Consistent failure to meet earnings estimates (1/4 beats in last 4 quarters)
MCTA BEARISH

MCTA exhibits a severe disconnect between its market price and fundamental value, with a Piotroski F-Score of 6/9 indicating stable internal health but failing to justify a valuation that dwarfs its Graham Number ($0.07) and Intrinsic Value ($0.49). The company is trading at an astronomical Price-to-Book ratio of 9785.00 and a P/E of 419.36 despite a significant revenue contraction of 27% YoY. While gross margins are exceptionally high, negative operating margins and a current ratio of 0.59 signal poor operational efficiency and liquidity risks. The technical trend is heavily bearish, suggesting a speculative bubble that is currently deflating.

Strengths
Stable Piotroski F-Score (6/9)
Exceptionally high gross margins (96.02%)
Positive net profit margin (12.12%)
Risks
Extreme overvaluation (Price vs. Intrinsic Value)
Significant revenue decline (-27% YoY)
Severe liquidity risk (Current Ratio 0.59)

Compare Another Pair

IVVD vs MCTA: Head-to-Head Comparison

This page compares Invivyd, Inc. (IVVD) and Charming Medical Limited (MCTA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile